- URL: http://xtalks.com/Tumor-Assessment-in-Immunotherapy-Clinical-Trials.ashx
- Date: September 19, 2016
- Listed: August 19, 2016 7:51 am
- Expires: This ad has expired
This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy. Recommendations on when and how to apply each criterion will be reviewed as will case histories illustrating the clinical decision-making needed to determine if a patient should continue treatment.
Information about the ad poster
- Listed by: email@example.com
- Member Since: July 15, 2016
Other items listed by firstname.lastname@example.org
- Is Site Payment Escrow a Thing of the Past? YES!
- Avoid Patent Eclipse – Accelerate Your Study Start Up and Tracking
- Intro to the Microbiome
- Advanced Imaging in Oncology